M.I. Rudolph

1.2k total citations
42 papers, 930 citations indexed

About

M.I. Rudolph is a scholar working on Immunology, Social Psychology and Molecular Biology. According to data from OpenAlex, M.I. Rudolph has authored 42 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 12 papers in Social Psychology and 10 papers in Molecular Biology. Recurrent topics in M.I. Rudolph's work include Mast cells and histamine (15 papers), Neuroendocrine regulation and behavior (12 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). M.I. Rudolph is often cited by papers focused on Mast cells and histamine (15 papers), Neuroendocrine regulation and behavior (12 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). M.I. Rudolph collaborates with scholars based in Chile, Argentina and United States. M.I. Rudolph's co-authors include Waldo Sepúlveda, M.A. Cruz, Claudio González, I. Gina Rojas, Karin Reinicke, Alejandra Martínez, Loreto Spencer, Alicia Penissi, Victoria Gallardo and L. Arqueros and has published in prestigious journals such as Circulation Research, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

M.I. Rudolph

42 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.I. Rudolph Chile 17 340 194 178 173 145 42 930
Ralph Telgmann Germany 16 456 1.3× 315 1.6× 198 1.1× 99 0.6× 122 0.8× 30 1.2k
P. C. MacDonald United States 19 483 1.4× 225 1.2× 227 1.3× 85 0.5× 60 0.4× 34 1.4k
Edith Markoff United States 21 321 0.9× 329 1.7× 155 0.9× 73 0.4× 70 0.5× 41 1.2k
Jean‐Louis Vigne United States 22 536 1.6× 550 2.8× 163 0.9× 158 0.9× 125 0.9× 36 1.5k
Richard C. Nicholson Australia 14 571 1.7× 360 1.9× 97 0.5× 110 0.6× 47 0.3× 22 1.6k
Kayoko Maehara Japan 26 312 0.9× 468 2.4× 247 1.4× 140 0.8× 70 0.5× 57 1.5k
Koji Kugu Japan 21 300 0.9× 331 1.7× 424 2.4× 77 0.4× 62 0.4× 58 1.3k
Philippe Lluel France 21 124 0.4× 250 1.3× 54 0.3× 79 0.5× 99 0.7× 61 1.2k
Anoop K. Brar United States 17 667 2.0× 217 1.1× 176 1.0× 35 0.2× 51 0.4× 46 1.2k
Graham W. Aberdeen United States 17 243 0.7× 271 1.4× 202 1.1× 61 0.4× 51 0.4× 39 890

Countries citing papers authored by M.I. Rudolph

Since Specialization
Citations

This map shows the geographic impact of M.I. Rudolph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.I. Rudolph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.I. Rudolph more than expected).

Fields of papers citing papers by M.I. Rudolph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.I. Rudolph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.I. Rudolph. The network helps show where M.I. Rudolph may publish in the future.

Co-authorship network of co-authors of M.I. Rudolph

This figure shows the co-authorship network connecting the top 25 collaborators of M.I. Rudolph. A scholar is included among the top collaborators of M.I. Rudolph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.I. Rudolph. M.I. Rudolph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rudolph, M.I., et al.. (2012). Activation of human leukemic mast cell line LAD2 is modulated by dehydroleucodine and xanthatin. Leukemia & lymphoma. 53(9). 1795–1803. 12 indexed citations
2.
Penissi, Alicia, M.I. Rudolph, Teresa Fogal, et al.. (2009). Novel anti-ulcer α,β-unsaturated lactones inhibit compound 48/80-induced mast cell degranulation. European Journal of Pharmacology. 612(1-3). 122–130. 34 indexed citations
3.
Rudolph, M.I., Sandra Luza, Edilia Andrews, et al.. (2008). The Influence of Mast Cell Mediators on Migration of SW756 Cervical Carcinoma Cells. Journal of Pharmacological Sciences. 106(2). 208–218. 28 indexed citations
4.
Martinez‐Gamboa, Lorena, et al.. (2006). Oxidative Stress Markers in Plasma and Urine of Prepubertal Patients with Type 1 Diabetes Mellitus. Journal of Pediatric Endocrinology and Metabolism. 19(8). 995–1000. 23 indexed citations
5.
Martínez, Alejandra, et al.. (2005). Expression of apoptotic and cell proliferation regulatory proteins in actinic cheilitis. Journal of Oral Pathology and Medicine. 34(5). 257–262. 30 indexed citations
6.
Penissi, Alicia, Ramón Piezzi, Mercedes Villar-Navarro, & M.I. Rudolph. (2003). A New High-Performance Liquid Chromatographic Method for the Determination of Dehydroleucodine in Plant Extracts. Chromatographia. 58(9-10). 659–664. 3 indexed citations
7.
Penissi, Alicia, et al.. (2003). Effect of dehydroleucodine on histamine and serotonin release from mast cells in the isolated mouse jejunum. Inflammation Research. 52(5). 199–205. 5 indexed citations
8.
Pérez, R., et al.. (1997). Inhibition of xylazine induced uterine contractility by clenbuterol and nifedipine. Research in Veterinary Science. 63(1). 73–76. 9 indexed citations
9.
Villar-Navarro, Mercedes, et al.. (1995). Histamine, a neuromodulator of noradrenergic transmission in uterine horns from mice in diestrus. Biochemical Pharmacology. 50(3). 407–411. 7 indexed citations
10.
Pérez, R., et al.. (1994). A single intravenous high dose of cholic acid to a pregnant ewe does not affect fetal well-being. Research in Experimental Medicine. 194(1). 63–67. 8 indexed citations
11.
Medina, José Luís, et al.. (1993). Characterization and distribution of cholinesterase activity in mouse uterine horns: changes in estrous cycle. Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology. 106(2). 473–478. 3 indexed citations
12.
Rudolph, M.I., et al.. (1993). Distribution of mast cells and the effect of their mediators on contractility in human myometrium. BJOG An International Journal of Obstetrics & Gynaecology. 100(12). 1125–1130. 74 indexed citations
13.
Rudolph, M.I., et al.. (1992). Mast cells mediators evoke contractility and potentiate each other in mouse uterine horns. General Pharmacology The Vascular System. 23(5). 833–836. 34 indexed citations
14.
Medina, José Luís, et al.. (1992). Nicotine stimulates adrenergic terminals and inhibits contractions of mouse uterine horns. General Pharmacology The Vascular System. 23(3). 493–496. 2 indexed citations
15.
Neumann, Veronica, et al.. (1991). Effect of progesterone on norepinephrine release from mouse adrenergic terminals in vitro. General Pharmacology The Vascular System. 22(4). 647–650. 7 indexed citations
16.
Cruz, M.A., et al.. (1991). Effect of Histamine on Human Placental Chorionic Veins: Interaction with Serotonin. Pharmacology. 42(2). 86–90. 12 indexed citations
17.
Sepúlveda, Waldo, et al.. (1990). Changes in the response to adrenergic drugs on mouse uterine contractions during pregnancy. Life Sciences. 46(2). 99–104. 10 indexed citations
18.
González, Claudio, M.A. Cruz, Waldo Sepúlveda, & M.I. Rudolph. (1990). Effects of Serotonin on Vascular Tone of Isolated Human Placental Chorionic Veins. Gynecologic and Obstetric Investigation. 29(2). 88–91. 21 indexed citations
19.
Rudolph, M.I. & Gonzalo Bustos. (1986). Search of a l-glutamate receptor related to modulation of neurotransmission in the rat corpus striatum. Neurochemistry International. 8(4). 481–492. 5 indexed citations
20.
Rudolph, M.I., et al.. (1983). l-Glutamic acid, a neuromodulator of dopaminergic transmission in the rat corpus striatum☆. Neurochemistry International. 5(4). 479–486. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026